Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Simcere To Conduct Human Trial of BMS Cancer Drug

publication date: Nov 3, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Simcere Pharma has partnered with Bristol-Myers Squibb to co-develop a cancer molecule. In return for exclusive China rights to BMS-817378, a small molecule MET/VEGFR-2 inhibitor, Simcere will conduct a first-in-human clinical trial of the drug candidate as a first step toward SFDA approval. Financial details of the partnership were not disclosed. More details....

Stock Symbols: (NYSE: SCR) (NYSE: BMY)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners